JP2012511506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511506A5 JP2012511506A5 JP2011539029A JP2011539029A JP2012511506A5 JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5 JP 2011539029 A JP2011539029 A JP 2011539029A JP 2011539029 A JP2011539029 A JP 2011539029A JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5
- Authority
- JP
- Japan
- Prior art keywords
- human insulin
- desb30
- insulin
- amino acid
- analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 85
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims 85
- 101150019032 B29R gene Proteins 0.000 claims 15
- 239000004026 insulin derivative Substances 0.000 claims 15
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 14
- 125000000539 amino acid group Chemical group 0.000 claims 12
- 102200082905 rs35203747 Human genes 0.000 claims 10
- 102000004877 Insulin Human genes 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 229940125396 insulin Drugs 0.000 claims 2
- 108700004929 A8H,B25N,B27E,desB30- insulin Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 102220092852 rs754853086 Human genes 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08171086 | 2008-12-09 | ||
| EP08171086.5 | 2008-12-09 | ||
| EPPCT/EP2009/053017 | 2009-03-13 | ||
| PCT/EP2009/053017 WO2009115469A1 (en) | 2008-03-18 | 2009-03-13 | Protease stabilized, acylated insulin analogues |
| EP09161014.7 | 2009-05-25 | ||
| EP09161014 | 2009-05-25 | ||
| EP09161232 | 2009-05-27 | ||
| EP09161232.5 | 2009-05-27 | ||
| PCT/EP2009/066335 WO2010066636A1 (en) | 2008-12-09 | 2009-12-03 | Novel insulin analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012511506A JP2012511506A (ja) | 2012-05-24 |
| JP2012511506A5 true JP2012511506A5 (https=) | 2014-06-19 |
Family
ID=41651437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539029A Withdrawn JP2012511506A (ja) | 2008-12-09 | 2009-12-03 | 新規インスリンアナログ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110294729A1 (https=) |
| EP (1) | EP2376531A1 (https=) |
| JP (1) | JP2012511506A (https=) |
| CN (1) | CN102245633A (https=) |
| WO (1) | WO2010066636A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102037008B (zh) | 2008-03-18 | 2016-08-31 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定化的、酰化胰岛素类似物 |
| CN102933599A (zh) | 2010-06-23 | 2013-02-13 | 诺沃—诺迪斯克有限公司 | 包含额外的二硫键的人胰岛素 |
| EP2585484A1 (en) * | 2010-06-23 | 2013-05-01 | Novo Nordisk A/S | Insulin analogues containing additional disulfide bonds |
| RU2598273C2 (ru) | 2010-06-23 | 2016-09-20 | Ново Нордиск А/С | Производные инсулина, содержащие дополнительные дисульфидные связи |
| US9481721B2 (en) | 2012-04-11 | 2016-11-01 | Novo Nordisk A/S | Insulin formulations |
| US20150198619A1 (en) * | 2012-09-25 | 2015-07-16 | The Walter And Eliza Hall Institute Of Medical Research | Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain |
| US20140269611A1 (en) * | 2013-03-14 | 2014-09-18 | T-Mobile Usa, Inc. | Communication Handovers from Networks Using Unlicensed Spectrum to Circuit-Switched Networks |
| CR20190096A (es) | 2016-07-22 | 2019-09-16 | Walter & Eliza Hall Inst Medical Res | Análogos de insulina |
| TWI700091B (zh) | 2016-12-16 | 2020-08-01 | 丹麥商諾佛 儂迪克股份有限公司 | 含胰島素醫藥組成物 |
| SG11202106167XA (en) | 2018-12-11 | 2021-07-29 | Sanofi Sa | Insulin conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR900701842A (ko) * | 1988-07-20 | 1990-12-04 | 헨리 브뢰늄 | 인간 인슐린 동족체와 그를 포함하는 제제 |
| US5716927A (en) * | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
| AU631868B2 (en) * | 1989-04-20 | 1992-12-10 | Mount Sinai School Of Medicine Of The City University Of New York, The | Hepatospecific insulin analogues |
| US5268453A (en) * | 1991-08-08 | 1993-12-07 | Scios Inc. | Tissue-selective insulin analogs |
| US6746853B1 (en) * | 1999-05-19 | 2004-06-08 | Xencor, Inc. | Proteins with insulin-like activity useful in the treatment of diabetes |
| WO2000069901A2 (en) * | 1999-05-19 | 2000-11-23 | Xencor, Inc. | Proteins with insulin-like activity useful in the treatment of diabetes |
| DK2074141T3 (en) * | 2006-09-22 | 2016-11-28 | Novo Nordisk As | The protease resistant insulin analogues. |
| WO2009112583A2 (en) * | 2008-03-14 | 2009-09-17 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| CN102037008B (zh) * | 2008-03-18 | 2016-08-31 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定化的、酰化胰岛素类似物 |
-
2009
- 2009-12-03 JP JP2011539029A patent/JP2012511506A/ja not_active Withdrawn
- 2009-12-03 WO PCT/EP2009/066335 patent/WO2010066636A1/en not_active Ceased
- 2009-12-03 CN CN2009801494190A patent/CN102245633A/zh not_active Withdrawn
- 2009-12-03 EP EP09771326A patent/EP2376531A1/en not_active Withdrawn
- 2009-12-03 US US13/133,465 patent/US20110294729A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511506A5 (https=) | ||
| WO2014071405A3 (en) | Long-acting single-chain insulin analogues | |
| WO2010014946A3 (en) | Halogen-stabilized insulin | |
| JP2013530974A5 (https=) | ||
| JP2018505146A5 (https=) | ||
| WO2009112583A3 (en) | Protease-stabilized insulin analogues | |
| WO2013002580A3 (ko) | 폴리에틸렌글라이콜 또는 이의 유도체로 페길화된 엑센딘-4 유사체, 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물 | |
| Gonçalves et al. | Denture adhesives improve mastication in denture wearers | |
| WO2015128403A3 (en) | An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue | |
| MY167234A (en) | Novel glucagon analogues | |
| JP2013530702A5 (https=) | ||
| JP2017500289A5 (https=) | ||
| HK1211232A1 (en) | Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists | |
| MX2013011175A (es) | Analogos de glucagon novedosos. | |
| JP2013542919A5 (https=) | ||
| EP2581389A4 (en) | FUSION PROTEIN FROM EXENDIN-4 AND ANALOG FROM THIS AND THE PRODUCTION PROCESS THEREFOR AND USE THEREOF | |
| EP2570873A3 (en) | Watch with shapeable strap | |
| WO2011072288A3 (en) | Insulin analogues with chlorinated amino acids | |
| RU2012157683A (ru) | Производные инсулина, содержащие дополнительные дисульфидные связи | |
| WO2014195966A3 (en) | Amorphous form of canagliflozin and process for preparing thereof | |
| WO2016105545A3 (en) | Insulin analogues with enhanced stabilized and reduced mitogenicity | |
| WO2011112867A8 (en) | The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas | |
| JP2017532343A5 (https=) | ||
| JP2015513544A5 (https=) | ||
| MX350195B (es) | Analogos de cistamina para el tratamiento de la enfermedad de parkinson. |